Angiotensin and bradykinin peptides in rats with myocardial infarction

Journal of Cardiac Failure

Volumn 3, Issue 1, 1997, Pages 41-52

  Duncan, Ann Maree ^a   Burrell, Louise M ^b   Kladis, Athena ^a   Campbell, Duncan J ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Angiotensin; Bradykinin; Cardiac failure; Cardiac hypertrophy; Myocardial infarction

Indexed keywords

ANGIOTENSIN II; BRADYKININ; RENIN;

ANIMAL; AORTA; ARTICLE; BLOOD; BLOOD PRESSURE; HEART INFARCTION; HEART MUSCLE; KIDNEY; LUNG; MALE; METABOLISM; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY; RAT; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; BRADYKININ; KIDNEY; LUNG; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RENIN;

EID: 0031090008     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90007-5     Document Type: Article

References (53)

1. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990;81:1161-72
2. Goldman S, Raya TE: Rat infarct model of myocardial infarction and heart failure. J Cardiac Failure 1995;1: 169-77
3. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75:977-84
4. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y: Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res 1995;77:258-65
5. Sadoshima J, Izumo S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype. Circ Res 1993;73:413-23
6. Crawford DC, Chobanian AV, Brecher P: Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 1994;74:727-39
7. Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg EO, Izumo S, Riegger G, Lorell BH: Angiotensin II-induced growth responses in isolated adult rat hearts: Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res 1995;76:489-97
8. 1 receptor. Am J Hypertens 1992;5:276-80
9. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA: Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49
10. Martorana PA, Kettenbach B, Breipohl G, Linz W, Schölkens BA: Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 1990;182:395-6
11. Chahine R, Adam A, Yamaguchi N, Gaspo R, Regoli D, Nadeau R: Protective effects of bradykinin on the ischaemic heart: Implication of the B1 receptor. Br J Pharmacol 1993;108:318-22
12. Zhu P, Zaugg CE, Simper D, Hornstein P, Allegrini PR, Buser PT: Bradykinin improves postischaemic recovery in the rat heart: Role of high energy phosphates, nitric oxide, and prostacyclin. Cardiovasc Res 1995;29:658-63
13. Goto M, Liu YG, Yang XM, Ardell JL, Cohen MV, Downey JM: Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77: 611-21
14. Wall TM, Sheehy R, Hartman JC: Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994; 270:681-9
15. Michel J-B, Lattion A-L, Salzmann J-L, de Lourdes Cerol M, Philippe M, Camilleri J-P, Corvol P: Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988;62:641-50
16. Fabris B, Jackson B, Kohzuki M, Perich R, Johnston CI: Increased cardiac angiotensin-converting enzyme in rats with chronic heart failure. Clin Exp Pharmacol Physiol 1990;17:309-14
17. Hirsch AT, Talsness CE, Schukert H, Paul M, Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69:475-82
18. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT: Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994;28:1423-32
19. Falkenhahn M, Franke F, Bohle RM, Zhu Y-C, Stauss HM, Bachmann S, Danilov S, Unger T: Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 1995;25:219-26
20. Passier RCJJ, Smits JFM, Verluyten MJA, Studer R, Drexler H, Daemen MJAP: Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol 1995;269:H1268-76
21. Lindpaintner K, Lu W, Niedermajer N, Schieffer B, Just H, Ganten D, Drexler H: Selective activation of cardiac angiotensittogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol 1993;25: 133-43
22. Meggs LG, Coupet J, Huang H, Cheng W, Li P, Capasso JM, Homey CJ, Anversa P: Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res 1993;72:1149-62
23. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M: Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95:46-54
24. Kimura E, Hashimoto K, Furukawa S, Hayakawa H: Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am Heart J 1973;85:635-47
25. Noda K, Sasaguri M, Ideishi M, Ikeda M, Arakawa K: Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res 1993;27:334-40
26. Matsuki T, Shoji T, Yoshida S, Kudoh Y, Motoe M, Inoue M, Nakata T, Hosoda S, Shimamoto K, Yellon D, Iimura O: Sympathetically induced myocardial ischemia causes the heart to release plasma bradykinin. Cardiovasc Res 1987;21:428-32
27. Campbell DJ, Kladis A, Duncan A-M: Bradykinin peptides in kidney, blood, and other tissues of the rat. Hypertension 1993;21:155-65
28. Campbell DJ, Kladis A, Duncan A-M: Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994;23:439-49
29. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P: Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985;72: 406-12
30. Hodsman GP, Kohzuki M, Howes LG, Sumithran E, Tsunoda K, Johnston CI: Neurohumoral responses to chronic myocardial infarction in rats. Circulation 1988; 78:376-81
31. Duncan A-M, Burrell LM, Kladis A, Campbell DJ: Effects of angiotensin converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. J Cardiovasc Pharmacol 1996;28:746-54
32. Oates HF, Stokes GS: Renin stimulation caused by blood collection techniques in the rat. Clin Exp Pharmacol Physiol 1974;1:495-501
33. Pettinger WA, Marchelle M, Augusto L: Renin supression by DOC and NaCl in the rat. Am J Physiol 1971;221: 1071-4
34. Campbell DJ, Kladis A, Duncan A-M: Nephrectomy, converting enzyme inhibition and angiotensin peptides. Hypertension 1993;22:513-22
35. Campbell DJ, Rong P, Kladis A, Rees B, Skinner SL: Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension 1995;25:1014-20
36. Campbell DJ, Lawrence AC, Kladis A, Duncan A-M: Strategies for measurement of angiotensin and bradykinin peptides and their metabolites in central nervous system and other tissues. In Smith AI: Methods in Neurosciences, volume 23: Peptidases and Neuropeptide Processing. Academic Press, Orlando, 1995, pp. 328-43
37. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ: Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991;18:763-73
38. Johansen KB, Marstein S, Aas P: Automated method for the determination of angiotensin-converting enzyme in serum. Scand J Clin Lab Invest 1987;47:411-14
39. Ludbrook J: On making multiple comparisons in clinical and experimental pharmacology and physiology. Clin Exp Pharmacol Physiol 1991;18:379-92
40. Gaballa MA, Raya TE, Goldman S: Large artery remodeling after myocardial infarction. Am J Physiol 1995;268: H2092-103
41. Gay R, Wool S, Paquin M, Goldman S: Total vascular pressure-volume relationship in conscious rats with chronic heart failure. Am J Physiol 1986;251:H483-9
42. Volpe M, Tritto C, DeLuca N, Rubattu S, Rao MAE, Lamenza F, Mirante A, Enea I, Rendina V. Mele AF, Trimarco B, Condorelli M: Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation 1993;88: 1620-7
43. Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC: Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated cardiac failure. Circulation 1989;80:299-305
44. Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T: Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol 1993;25:1369-80
45. Fishbein MC, Maclean D, Maroko PR: Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 1978;90:57-70
46. Dray A, Perkins M: Bradykinin and inflammatory pain. TINS 1993;16:99-104
47. Nolly H, Carbini LA, Scicli G, Carretero OA, Scicli AG: A local kallikrein-kinin system is present in rat hearts. Hypertension 1994;23:919-23
48. Dubey RK: Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells. J Pharmacol Exp Ther 1994;269:402-8
49. McAllister BS, Leeb-Lundberg F, Olson MS: Bradykinin inhibition of EGF- and PDGF-induced DNA synthesis in human fibroblasts. Am J Physiol 1993;265:C477-84
50. Schölkens BA, Linz W, Konig W: Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischemic rat heart are abolished by a bradykinin antagonist. J Hypertens 1988;6(Suppl 4):S25-8
51. Linz W, Martorana PA, Schölkens BA: Local inhibition of bradykinin degradation in ischemic hearts. J Cardiovasc Pharmacol 1990;15(Suppl. 6):S99-S109
52. Linz W, Schölkens BA: A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol 1992;105:771-2
53. McDonald KM, Mock J, D'Aloia A, Parrish T, Hauer K, Francis G, Stillman A, Cohn JN: Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. Circulation 1995;91:2043-8